European Anti-Doping Agencies Raise Concerns Over U.S. Testing Ahead of Paris Olympics

More than 30 European anti-doping agencies expressed concern about inadequate doping tests for U.S. professional and college athletes ahead of the Paris Olympics. They urged WADA to conduct an in-depth assessment, highlighting gaps in testing within American sports leagues and the NCAA, raising questions about WADA's effectiveness and independence.

More than 30 European anti-doping agencies expressed their concerns on Thursday, through a letter that appears directed at the United States, regarding the inadequate doping tests for professional and college athletes participating in major events such as the upcoming Paris Olympics.

The agencies pointed out that these athletes are not adhering to the World Anti-Doping Agency's (WADA) code and called for a comprehensive review by WADA. Although they did not explicitly single out the U.S., the lack of stringent testing within American sports leagues—such as the NFL, MLB, NBA, and NHL—has long been considered a significant loophole by anti-doping officials.

A spokesperson from the Central European Anti-Doping Organisation (CEADO) highlighted in an open letter the alarming rate of insufficiently tested athletes by referencing available data. Calls were made for U.S. authorities to improve testing measures, questioning the commitment of WADA amid recent controversies involving Chinese athletes cleared to compete in the Tokyo Games.

(With inputs from agencies.)